GENE ONLINE|News &
Opinion
Blog

Sanofi
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
Sanofi/GSK Vaccine Delayed Due to Poor Immunogenicity in Older Adults
2020-12-15
Sanofi Offers to Buy Kiadis Pharma to Advance Immuno-Oncology Research
2020-11-03
Entering Late into the COVID-19 Vaccine Race, Could this Pharma Duo Measure up to Competition?
2020-09-06
Sanofi Advances in Multiple Sclerosis Market with Principia Acquisition Deal
2020-08-18
BioNTech to Test mRNA-Based Cancer Vaccine with Regeneron’s anti-PD1 Drug in Melanoma Patients
2020-08-04
Kymera Inks US$ 150M Deal with Sanofi for Potential Rheumatoid Arthritis and Eczema Treatments
2020-07-12
Pioneers Sanofi, GSK to Jointly Develop COVID-19 Vaccine
2020-04-15
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
1 2 3 4
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!